FDA Inspection 754956 — Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd.

Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. — FEI 3006772356

The FDA completed an inspection of Livzon Group Fuzhou Fuxing Pharmaceutical Co., Ltd. on Nov 11, 2011 in Fuzhou. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Nov 11, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fuzhou (China)